Mitsubishi Chemical America has entered into a definitive agreement to acquire all of the issued and outstanding shares of Gelest Intermediate Holdings, the parent of Gelest, and a portfolio company of New Mountain Capital.
The transaction is expected to be completed in 2020, pending customary regulatory review and approval.
Gelest is an American innovator, manufacturer, and supplier of silicones, organosilanes, metal-organics, and specialty monomers for advanced technology end markets including medical devices, life sciences, microelectronics, and personal care. Gelest helps customers succeed by assisting them to develop and supply the chemistry to solve their most challenging materials science problems and enable their new product technology.
Steve Yurich, president of MCA, said: “We are excited to acquire Gelest as its business fits well within MCC’s long-term strategy. Since becoming familiar with Gelest, we have recognised the tremendous capabilities in research and development and production that help create its outstanding position with key customers. Furthermore, MCC’s operating resources and customer network will enhance the ability to bring Gelest’s technologies to market and accelerate the development of new customer solutions to drive advances in digital social infrastructure, vision care, and other life sciences applications. We look forward to working alongside the team at Gelest to drive the continued growth of the company.”
Ken Gayer, CEO of Gelest, added: “We are excited to join MCC during our next stage of growth. MCC’s breadth and depth in the advanced materials sector will allow Gelest to create even more value for our customers and opportunities for our employees.”